PURPOSE AND EFFECT: This rule development will consider rules necessary to adopt the form used to apply for participation as an Exporter in the International Prescription Drug Importation Program as authorized by 499.0285, F.S., 21 U.S.C. § 384 and 21 C.F.R. Part 251.
SUBJECT AREA TO BE ADDRESSED: International Prescription Drug Importation Program
RULEMAKING AUTHORITY: 499.0285
LAW IMPLEMENTED: 499.01, 499.0285
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Taya Orozco, Senior Legal Assistant, Office of the General Counsel, Division of Drugs, Devices, and Cosmetics, Department of Business and Professional Regulation; taya.orozco@myfloridalicense.com or (850)717-1177.